Log in

NASDAQ:IMRAPassage Bio Stock Price, Forecast & News

0.00 (0.00 %)
(As of 04/5/2020 11:59 AM ET)
Today's Range
Now: $15.75
50-Day Range N/A
52-Week Range
Now: $15.75
Volume15,009 shs
Average Volume35,892 shs
Market Capitalization$261.14 million
P/E RatioN/A
Dividend YieldN/A
Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.10 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:IMRA



Sales & Book Value

Annual SalesN/A



Market Cap$261.14 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRA and its competitors with MarketBeat's FREE daily newsletter.

Passage Bio (NASDAQ:IMRA) Frequently Asked Questions

Has Passage Bio been receiving favorable news coverage?

Media coverage about IMRA stock has trended very negative recently, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Passage Bio earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutPassage Bio.

Who are some of Passage Bio's key competitors?

Who are Passage Bio's key executives?

Passage Bio's management team includes the following people:
  • Dr. Rahul D. Ballal Ph.D., Pres, CEO & Director (Age 42)
  • Mr. Michael P. Gray CPA, M.B.A., MBA, CPA, CFO & COO (Age 49)
  • Dr. Willem H. Scheele M.D., Chief Medical Officer (Age 59)
  • Dr. James G. McArthur, Founder & Director (Age 58)
  • Mr. Frank Waligora, VP of Technical Operations

When did Passage Bio IPO?

(IMRA) raised $76 million in an IPO on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

What is Passage Bio's stock symbol?

Passage Bio trades on the NASDAQ under the ticker symbol "IMRA."

When does the company's quiet period expire?

Passage Bio's quiet period expires on Tuesday, April 21st. Passage Bio had issued 4,700,000 shares in its IPO on March 12th. The total size of the offering was $75,200,000 based on an initial share price of $16.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Passage Bio?

Shares of IMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Passage Bio's stock price today?

One share of IMRA stock can currently be purchased for approximately $15.75.

How big of a company is Passage Bio?

Passage Bio has a market capitalization of $261.14 million. Passage Bio employs 16 workers across the globe. View additional information about Passage Bio.

What is Passage Bio's official website?

The official website for Passage Bio is http://www.imaratx.com/.

How can I contact Passage Bio?

Passage Bio's mailing address is 116 HUNTINGTON AVENUE 6TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-206-2020 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: After-Hours Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel